Mulligan Mobilization vs Shockwave Therapy in Adhesive Capsulitis

NCT07310810 | Active Not Recruiting

• 1 other identifier: 012/005863
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

To investigate and compare the effects of Mulligan mobilization versus shock wave therapy in patients with adhesive capsulitis on Pain intensity level, Range of motion, Functional disability level, Ultrasonographic changes (soft tissue thickness) and Hand grip strength.

Conditions

Adhesive Capsulitis

Keywords

Adhesive capsulitis; Mulligan mobilization; EXTRACORPOREAL SHOCKWAVE THERAPY; ULTRASONOGRAPHIC CHANGES

Outcome Measures

Primary Outcomes (5)

• Pain intensity level.

  measured by Visual analog scale

  4 weeks

• Range of motion.

  measured by digital goniometer

  4 weeks

• Functional disability level.

  Determined by Disabilities of the arm, shoulder and hand questionnaire (DASH)

  4 weeks

• Soft tissue thickness (Capsule thickness)

  measured by musculoskeletal ultrasonography

  4 weeks

• Hand grip strength

  Measured by hand dynamometer

  4 weeks

Study Arms (3)

- Group A (study group)

EXPERIMENTAL

received mulligan technique and conventional treatment

Other: Mulligan mobilization; Other: Conventional treatment

Group B (study group)

EXPERIMENTAL

received extracorporeal shockwave therapy and conventional treatment.

Device: Shockwave; Other: Conventional treatment

Group C (control group)

EXPERIMENTAL

received conventional treatment only.

Other: Conventional treatment

Interventions

Shockwave DEVICE

From sitting with shoulder abducted at 45 degree and elbow flexed and the forearm rested on flat surface, The patients in the intervention group B received shock wave therapy once a week for 4 weeks. The focus probe sets were used and, in each session, patients received ESWT from anterior and posterior directions (on the average 1200 shocks between 0.1 and 0.3 mJ/mm2) up to the maximum threshold of pain tolerance in the shoulder

Group B (study group)

Mulligan mobilization OTHER

Mobilization with movement (MWM) is the concurrent application of sustained accessory mobilization applied by a therapist and an active physiological movement to end range applied by the patient. Passive end-of-range overpressure, or stretching, is then delivered without pain as a barrier

Also known as: Mobilization with movement

- Group A (study group)

Conventional treatment OTHER

Conventional treatment will be axillary ultrasound and laser ,low loading stretching exercise and home program exercises

- Group A (study group); Group B (study group); Group C (control group)

Eligibility Criteria

• Age: 40 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Patients referred from orthopedist and diagnosed as frozen shoulder The age of the participant will be from 40-60 (Agarwal S., et al.2016). Body mass index from 25- 30 kg/m2. having a painful stiff shoulder for at least 3 months having limited ROM of a shoulder joint (ROM losses of 25% or greater compared with the noninvolved shoulder in at least 2 of the following shoulder motions: glenohumeral flexion, abduction and lateral rotation.
• ability to complete Disabilities of the Arm, Shoulder and Hand questionnaires (DASH).

You may not qualify if:

• history of surgery on the particular shoulder Rheumatoid arthritis painful stiff shoulder after a severe trauma fracture of the shoulder complex rotator cuff rupture tendon calcification.

Sponsors & Collaborators

• Cairo University: lead

Study Sites (1)

Faculty of Physical Therapy

Giza, 12612, Egypt

Location

MeSH Terms

Conditions

Bursitis

Interventions

Movement

Condition Hierarchy (Ancestors)

Joint Diseases; Musculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Physiological Phenomena; Musculoskeletal Physiological Phenomena; Musculoskeletal and Neural Physiological Phenomena

Study Officials

• Mohamed R Gaber, Asst. lect.

  Cairo University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: lecturer assistant

Study Record Dates

• First Submitted: December 16, 2025
• First Posted: December 30, 2025
• Study Start: May 1, 2025
• Primary Completion: January 1, 2026
• Study Completion: February 1, 2026
• Last Updated: December 30, 2025

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)